European Journal of Pharmaceutical Sciences is a peer reviewed, open access journal.
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by your choice of one of the following user licenses:
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
Article Publishing Charge
As an open access journal with no subscription charges, a fee (Article Publishing Charge, APC) is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.The Article Publishing Charge for this journal is USD 2300, excluding taxes.
Please note: Authors who have submitted their paper on or before the 30th of September 2021, will have their accepted article published in European Journal of Pharmaceutical Sciences at no charge. Authors submitting their paper after this date will be requested to pay the APC. For more details visit our FAQs page.
Research4Life Article Publishing Charge waiver & discount optionsWe automatically apply Article Publishing Charge waivers or discounts to those articles in gold open access journals for which all authors are based in a country eligible for the Research4Life program. Find out more about the APC waiver and discount eligibility here.
Best price promise
Our Online Author Communication System (OACS) ensures you are offered the lowest possible Article Publishing Charge to publish an article in your chosen journal. During submission you will be presented with a personalized OA Article Publishing Charge based on your individual context (your country, institutional affiliation, and any society membership for example) as well as considering the journal involved.Learn more about Elsevier's pricing policy.
Open access agreements
Elsevier has reached open access agreements with an increasing number of institutions and university consortia around the world. Find out what this means for authors on our open access agreements page.
Funding arrangementsElsevier partners with funding bodies to provide guidance for authors on how to comply with funding body open access policies. Find out more on our funding arrangements page.
For open access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and Elsevier will be granted publishing and distribution rights.
Elsevier supports responsible sharingFind out how you can share your research published in Elsevier journals.
Learn more about:
- Benefits of publishing open access with Elsevier
- Open access agreements
- Funding arrangements
- Open access license policy
- Open access pricing policy
Contact detailsJournal Article Publishing Support Center